ClinicalTrials.gg
Status unknownNCT02768428Updated May 11, 2016

Effectiveness of Knowledge by Video and Handbook of Liver Cancer Patients With First Trans-arterial Chemoembolization

An interventional study of Video-Audio Media in Cancer, sponsored by Chulabhorn Hospital. Status unknown at 1 site in Thailand. Open to participants aged 20 Years to 75 Years. Per ClinicalTrials.gov, last updated 2016-05-11.

Sponsored by Chulabhorn Hospital · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified May 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
20 Years to 75 Years
Sex
All
01

Study summary

Objective: To compare the effectiveness between Video and Handbook on providing knowledge of TACE.

Study Design: A prospective, randomized, controlled trial.

Read the detailed description

Background : Liver cancer is a serious disease with a high death rate. One of the treatment modalities for liver cancer is TACE. Patients always scare of the first TACE due to their lack of knowledge and inadequate comprehension of the procedure. Hence, they crave to have a good quality in nursing service. Researcher would like to compare the effectiveness knowledge between Video and Handbook regarding patients' health education.

Objective: To compare the effectiveness between Video and Handbook on providing knowledge of TACE.

Study Design: A prospective, randomized, controlled trial.

Setting: Chulabhorn Hospital, Bangkok, THAILAND.

Methods : Eighty liver cancer patients are included in the study. They are systematically computerized and randomized into two groups - an experiment or video group (N 40) and a control or Handbook group (N = 40). A 40-item exam is performed to test the patients' knowledge before (x score), after (y score) and 60 days (z score) after the procedure. The 15-min study was taken in an isolated room. The points of interest are the effectiveness of medias on learning achievement and relative growth of knowledge. The relative growth of knowledge (G1, G2 score) was calculated as follows:

G1 = 100 (Y-X)/(F-X) % ; G2 = 100 (Z-X)/(F-X)%

Retention of knowledge (R) = 100 - (G1 - G2) %

Where G = Relative growth of knowledge R = Retention of knowledge X = Pre-test score Y = Post-test score Z = Final-test score F = Total score

02

Conditions studied

  • Cancer

Browse trials for

Keywords

  • Knowledge [K01.468]
  • Video-Audio Media [V01.255.500]
  • Handbooks [V02.520]
03

In context

Neoplasms

10,822 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.

This study's planned enrollment of 80 is above the median of 60 across 7,704 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Chulabhorn Hospital is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 20 - 75 years
  • Willing to participate the study
  • 1st TACE
  • Can comprehend all information in video or handbook
  • No trouble of hearing
  • Can complete the 40-item test

Exclusion criteria

Exclusion Criteria:

  • Have psychological/mental problems
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Video-Audio Media

    watching the entire video in 15 mins

    Other: Video-Audio Media

  • No intervention
    Handbooks

    study the hand book in 15 mins

Interventions

  • OtherVideo-Audio Media

    each arm spends 15 mins for watching the video or study the handbooks

    Also known as: Handbooks

06

What researchers measure

Primary outcomes

  1. knowledge about TACE (A 40-item exam is performed to test the patients' knowledge)

    The points of interest are the effectiveness of medias on learning achievement and relative growth of knowledge.

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
  • Chulabhorn Hospital
    Thailand, Bangkok 10210, Thailand
    Recruiting
08

References and documents

Publications

  • Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13. PubMed 18477802 ↗
  • Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, Ayuso C, Castells L, Montana X, Llovet JM, Bruix J. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007 Mar;46(3):474-81. doi: 10.1016/j.jhep.2006.10.020. Epub 2006 Nov 29. PubMed 17239480 ↗
  • McCurdy HM. Improving outcomes for patients receiving transarterial chemoembolization for hepatocellular carcinoma. Gastroenterol Nurs. 2013 Mar-Apr;36(2):114-20. doi: 10.1097/SGA.0b013e318288c8be. PubMed 23549214 ↗
  • Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996 Dec;49(12):1373-9. doi: 10.1016/s0895-4356(96)00236-3. PubMed 8970487 ↗
  • Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(9856):1840-50. doi: 10.1016/S0140-6736(12)60919-2. Epub 2012 Oct 16. PubMed 23079588 ↗

Individual participant data

Plan to share: Yes

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2015, a primary completion of Oct 2017 and a completion of Oct 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 18, 2016
First posted
May 11, 2016
Start
Oct 2015
Primary completionEst.
Oct 2017
CompletionEst.
Oct 2017
Last update
May 11, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02768428
Lead sponsor
Chulabhorn Hospital
Responsible party
Ruechuta Molek (Registered Nurse, Chulabhorn Hospital) — Principal investigator
First posted
May 11, 2016
Start date
Oct 2015
Primary completion
Oct 2017 (estimated)
Completion
Oct 2017 (estimated)
Last update
May 11, 2016

Study contacts

Ruechuta Molek, MNS
Contact
ruechuta.molek@gmail.com
+66818661516
Chaivej Nuchprayoon, Prof.
Contact
chaivej@hotmail.com
+6625766840
Ruechuta Molek, MNS
principal investigator · Chulabhorn Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion